Dr Fakhar Khan
Consultant Cardiologist and Electrophysiologist
MA (CANTAB),MBBChir, MRCP (UK), CCDS,CEPS
Dr Fakhar Khan is a Consultant Cardiologist, with a specialist interest in the management of patients with heart rhythm disorders. He is based at The Heart Hospital in London, part of University College London Hospitals NHS Trust, and at the Royal Free Hospital in Hampstead.
He gained his medical degree from the University of Cambridge in 1999. Subsequent to this, he pursued his training in General Medicine and Cardiology in Oxford, London and then Cambridge, at Papworth Hospital and Addenbrooke’s Hospital. He then furthered his training in Canada, where Dr Khan was awarded the Mirium L Burnett Fellowship in Electrophysiology and Devices in Toronto, working with some of the leading experts in the field.
He has a strong research record, publishing many peer reviewed articles, and is an invited speaker at international conferences and meetings in the US and Europe. In addition to this, he has completed a Medical Doctorate at the University of Cambridge, where he led a major clinical trial on improving outcomes for patients needing cardiac resynchronization therapy. In recognition of his achievements he was awarded the Young Investigator Award in 2010 by the Heart Rhythm Society UK.
In his current role, as a full time clinician, he regularly performs procedures for the treatment of heart rhythm disorders including the insertion of pacemakers, defibrillators, cardiac resynchronization therapy and all aspects of ablation therapy including the treatment of supraventricular tachycardia, atrial fibrillation, ventricular tachycardia, and rhythm disorders in patients with adult congenital heart disease.
Dr Khan is passionate about patient centred care and makes a clear and comprehensive assessment of all patients. He takes the time to explain any tests or treatment and considers all alternative options ensuring that patients are fully informed and involved in all aspects of their care. Dr Khan is available to see NHS and private patients and is a recognised healthcare provider with BUPA, AXA PPP, Cigna, Pru Health, Aviva, Simply Health and others.
The management of Heart Failure
Implantable cardiac defibrillators
Cardiac resynchronization therapy
Ablation therapy for SVT
All aspects of cardiac rhythm management, heart failure.
All aspects of cardiac rhythm management
Cardiac resynchronization therapy
Implantable cardiac defibrillators.
He has a strong research record, publishing many peer reviewed articles, and is an invited speaker at international conferences and meetings in the US and Europe.
In addition to this, he has completed a Medical Doctorate at the University of Cambridge, where he led a major clinical trial on improving outcomes for patients needing cardiac resynchronization therapy. In recognition of his achievements he was awarded the Young Investigator Award in 2010 by the Heart Rhythm Society UK.
Khan FZ, Dutka DP, Fynn SP ‘Recorded spontaneous sudden cardiac death in association with pre-excited atrial fibrillation.’ Europace (2009) Jan;11(1):124-26
Khan FZ, Virdee MS, Fynn SP, Dutka DP ‘Left Ventricular Lead Placement in Cardiac Resynchronization Therapy – Where and how?’ Europace (2009) May;11(5):554-61
Hickson SS, Butlin M, Mir FA, Graggaber J, Cheriyan J, Khan FZ, Grace AA, Yasmin, Cockcroft JR, Wilkinson I McEniery CM The accuracy of central systolic blood pressure determined from the second systolic peak of the peripheral pressure waveform. Journal of Hypertension (2009) Sep 27 (9):1784-8
Khan FZ, Virdee MS, O’Halloran D, Watson T, Fynn SP, Dutka DP Characterization of the suitability of coronary venous anatomy for targeting left ventricular lead placement in patients undergoing cardiac resynchronization therapy. Europace (2009) November (11) 1491-1495
Khan FZ, Virdee MS, Pugh PJ, Read PA, Fynn SP, Dutka DP Non Invasive Cardiac Output Measurements Based on Bioreactance for Optimization of AV and VV Delays. Europace 2009 December 11(12) 1666-74
Read PA, Khan FZ, Heck PM, Hoole SP, Dutka DP In patients with coronary artery disease, DPP 4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease. Circulation Cardiovascular Imaging 2010 3(2):195-201
Khan FZ, Virdee MS, Read PA, Pugh PJ, O’Halloran D, Fahey M, Elsik M, Begley D, Fynn SP, Dutka DP Effect of low amplitude 2D radial strain at left ventricular pacing sites on response to cardiac resynchronization therapy Journal American Society of Echocardiography 2010 23 (11) 1168-76
Khan FZ, Salahshouri P, Duemke R, Read PA, Pugh PJ, Elsik M, Begley D, Fynn SP, Dutka DP, Virdee MS The impact of the right ventricular lead position on response to cardiac resynchronization therapy. Pacing and Clinical Electrophysiology 2011 34(4):467-74
Nayar V, Khan FZ, Pugh PJ Optimizing atrioventricular and interventricular intervals following cardiac resynchronization therapy Expert Rev Cardiovasc Ther 2011 9 (2): 185-197
Khan FZ, Virdee MS, Read PA, Pugh PJ, Begley D, Fynn SP, Dutka DP Impact of VV Optimization According to LV Lead Position: An Acute Haemodynamic Study Europace 2011 13(6) 845-52
Read PA, Khan FZ, Dutka GLP 1 infusion improves the myocardial response to dobutamine stress and mitigates stunning in patients with coronary artery disease Heart 2011
Read PA, Hoole, White PA, Khan FZ, West NE, O’Sullivan M, Dutka DP GLP 1 infusion mitigates stunning and LV dysfunction following ballon occlusion during PCI in humans Circulation: Cardiovascular Imaging 2011 4(3) 266-7
Khan FZ, Virdee MS, Read PA, Pugh PJ, Begley D, Fynn SP, Dutka DP Cardiac Resynchronization Therapy Optimization Using Non Invasive Cardiac Output Monitoring Pacing and Clinical Electrophysiology 2011 34 (11) 1527-36
Khan FZ, Virdee MS, Read PA, Pugh PJ, Begley D, Fynn SP, Dutka DP Targeted left ventricular lead placement to guide cardiac resynchronization therapy: The TARGET Study: A Randomised Controlled Trial Journal of the American College of Cardiology 2012 Vol 59(17) 1509-18
Khan FZ, Dutka DP QRS morphology is equally important: A reply Trial Journal of the American College of Cardiology 2012 60(9) 873
Kydd AC, Khan FZ, O’Halloran D, Peter PJ, Dutka DP Radial Strain Delay Based on Segmental Timing and Strain Amplitude Predicts Left Ventricular Reverse Remodeling and Survival following Cardiac Resynchronization Therapy Circulation: Cardiovascular Imaging 2013 6(2) 177-84
Webb A, Annamalai AK, Narayanan K, Gayton E, Elkhawad M, Maki-Petaja K, Pilsworth S, Wallace S, Khan F, O’Toole S, Ariyaratnam S, Halsall DJ, Scoffings DJ, Nagui MA, Wilkinson I, Dutka D, Shneerson J, Simpson HL, Gurnell M A comprehensive study of clinical, biochemical, radiological, vascular, cardiac and sleep parameters in an unselected cohort of patients with acromegaly undergoing pre-surgical somatostatin receptor ligand therapy Journal of Clinical Endocrinology and Metabolism 2013 98(3) 1040-50
Kydd AC, Khan F, Gopalan D, Ring L, Rana BS, Virdee MS, Dutka DP Utility of speckle tracking echocardiography to characterize dysfunctional myocardium in patients with ischemic cardiomyopathy referred for cardiac resynchronization therapy Echocardiography 2014 31(6) 736-43
Kydd AC, Khan FZ, Watson W, Peter PJ, Dutka DP The Prognostic Benefit of Optimum Left Ventricular Lead Position in CRT: Follow-up of the TARGET Study Cohort JACC HF 2014 2(3) 205-12
Looi KL, Gajendragadkar PR, Khan FZ, Elsik M, Begley DA, Fynn SP, Grace AA, Heck PM, Virdee M, Agarwal S Cardiac Resynchronization Therapy: pacemaker versus internal cardioverter defibrillator in patients with impaired left ventricular function Heart 2014 100(10) 794-9
Kydd AC, Khan FZ, Ring L, Pugh PJ, Virdee MS, Dutka DP Development of a multiparametric score to predict left ventricular remodelling and prognosis after cardiac resynchronization therapy Eur J Heart Fail. 2014 16(11):1206-13